Skip to content

Clinical trials

Observational Lung Diseases, Obstructive trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases, Obstructive Phase: Observational Country / region: United States Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20055
20161
20201
20221
20233

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Michigan5
Albert Einstein College of Medicine1
AstraZeneca1
Columbia University1
Convexity Scientific Inc1
MetroHealth Medical Center1
NYU Langone Health1
National Heart, Lung, and Blood Institute (NHLBI)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases, Obstructive12
Pulmonary Disease, Chronic Obstructive7
Lung Diseases5
Asthma2
Respiratory Tract Diseases2
Bronchial Diseases1
Cardiomyopathies1
Emphysema1
Genetic Diseases, Inborn1
Heart Failure1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.